| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,763 | 6,236 | 6,835 | 8,244 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 3,763 | 6,236 | 6,835 | 8,244 | | | Operating Expenses | | Research Development | 4,521 | 5,090 | 7,636 | 9,190 | | Selling General and Administrative | 1,530 | 1,414 | 1,731 | 1,927 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,288) | (268) | (2,532) | (2,873) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 613 | 233 | 387 | 867 | | Earnings Before Interest And Taxes | (1,675) | (35) | (2,145) | (2,006) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,675) | (35) | (2,145) | (2,006) | | Income Tax Expense | (363) | (1) | (321) | (617) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,312) | (34) | (1,824) | (1,389) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,312) | (34) | (1,824) | (1,389) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,312) | ($34) | ($1,824) | ($1,389) |
|
0.51% Nasdaq 
Income Statement
